Literature DB >> 944645

Suppression of ethanol withdrawal by dopamine.

K Blum, J D Eubanks, J E Wallace, H A Schwertner.   

Abstract

An ethanol-inhalation technique was used to determine a potential relationship between dopamine and central nervous effects produced by alcohol. Both L-DOPA and intracranially injected dopamine resulted in attenuation of ethanol-induced withdrawal convulsion scores, whereas, haloperidol, a known dopaminergic blocker was found to significantly increase convulsion scores.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 944645     DOI： 10.1007/bf01920816

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  17 in total

1.  Comparison of excited phases after sedatives and tranquilizers.

Authors:  G W READ; W CUTTING; A FURST
Journal:  Psychopharmacologia       Date:  1960-06-23

2.  Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse.

Authors:  T J HALEY; W G MCCORMICK
Journal:  Br J Pharmacol Chemother       Date:  1957-03

3.  Inhibition of ethanol-induced excitation in mice and rats by -methyl-p-tyrosine.

Authors:  A Carlsson; J Engel; T H Svensson
Journal:  Psychopharmacologia       Date:  1972

4.  Ethanol narcosis in mice: serotonergic involvement.

Authors:  K Blum; J E Wallace; W Calhoun; R G Tabor; J D Eubanks
Journal:  Experientia       Date:  1974-09-15

5.  Synergy of ethanol and alcohol-like metabolites: tryptophol and 3,4-dihydroxyphenylethanol.

Authors:  K Blum; W Calhoun; J H Merritt; J E Wallace
Journal:  Pharmacology       Date:  1973       Impact factor: 2.547

6.  L-DOPA: effect on ethanol narcosis and brain biogenic amines in mice.

Authors:  K Blum; W Calhoun; J Merritt; J E Wallace
Journal:  Nature       Date:  1973-04-06       Impact factor: 49.962

7.  The nerve impulse-blocking actions of tranquilizers and the binding of neuroleptics to synaptosome membranes.

Authors:  P Seeman; A Staiman; M Chau-Wong
Journal:  J Pharmacol Exp Ther       Date:  1974-07       Impact factor: 4.030

8.  Effect of tetrahydroisoquinoline derivatives on the adenylate cyclases of the caudate nucleus (dopamine-type) and erythrocyte (beta-type) of the rat.

Authors:  H Sheppard; C R Burghardt
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1974-07

9.  Tryptophol, 5-hydroxytryptophol and 5-methoxytryptophol induced sleep in mice.

Authors:  A Feldstein; F H Chang; J M Kucharski
Journal:  Life Sci       Date:  1970-03-15       Impact factor: 5.037

10.  Alcohol withdrawal reactions in mice: effects of drugs that modify neurotransmission.

Authors:  D B Goldstein
Journal:  J Pharmacol Exp Ther       Date:  1973-07       Impact factor: 4.030
View more
  10 in total

1.  Fifty Years in the Development of a Glutaminergic-Dopaminergic Optimization Complex (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome: A Pictorial.

Authors:  K Blum; M Febo; R D Badgaiyan
Journal:  Austin Addict Sci       Date:  2016-10-12

2.  Inhibition of brain dopa-decarboxylase by RO 4-4602 infused ICV blocks alcohol drinking induced in rats by cyanamide.

Authors:  F J Miñano; R D Myers
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  The effects of atropine on the tolerance and the convulsions seen after withdrawal from forced barbital drinking in the rat.

Authors:  G Wahlström
Journal:  Psychopharmacology (Berl)       Date:  1978-10-31       Impact factor: 4.530

4.  Effects of ethanol on turnover and function of striatal dopamine.

Authors:  H Lai; W L Makous; A Horita; H Leung
Journal:  Psychopharmacology (Berl)       Date:  1979-03-14       Impact factor: 4.530

5.  Hypothesizing Darkness Induced Alcohol Intake Linked to Dopaminergic Regulation of Brain Function.

Authors:  Kenneth Blum; Marlene Oscar-Berman; Rajendra Badgaiyan; Eric R Braverman; Mark S Gold
Journal:  Psychology (Irvine)       Date:  2014-03

6.  Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms.

Authors:  Kenneth Blum; Marlene Oscar-Berman; Elizabeth Stuller; David Miller; John Giordano; Siobhan Morse; Lee McCormick; William B Downs; Roger L Waite; Debmalya Barh; Dennis Neal; Eric R Braverman; Raquel Lohmann; Joan Borsten; Mary Hauser; David Han; Yijun Liu; Manya Helman; Thomas Simpatico
Journal:  J Addict Res Ther       Date:  2012-11-27

7.  Pro-Dopamine Regulator - (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS).

Authors:  Kenneth Blum; Marcelo Febo; Lyle Fried; David Baron; Eric R Braverman; Kristina Dushaj; Mona Li; Zsolt Demetrovics; Rajendra D Badgaiyan
Journal:  J Reward Defic Syndr Addict Sci       Date:  2017-04-28

Review 8.  Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape.

Authors:  Kenneth Blum; Marcelo Febo; Rajendra D Badgaiyan; Zsolt Demetrovics; Thomas Simpatico; Claudia Fahlke; Oscar-Berman M; Mona Li; Kristina Dushaj; Mark S Gold
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

9.  The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery.

Authors:  Kenneth Blum; Benjamin Thompson; Zsolt Demotrovics; John Femino; John Giordano; Marlene Oscar-Berman; Scott Teitelbaum; David E Smith; A Kennison Roy; Gozde Agan; James Fratantonio; Rajendra D Badgaiyan; Mark S Gold
Journal:  J Reward Defic Syndr       Date:  2015

10.  Would induction of dopamine homeostasis via coupling genetic addiction risk score (GARS®) and pro-dopamine regulation benefit benzodiazepine use disorder (BUD)?

Authors:  K Blum; M Gold; E J Modestino; D Baron; B Boyett; D Siwicki; L Lott; A Podesta; A K Roy; M Hauser; B W Downs; R D Badgaiyan
Journal:  J Syst Integr Neurosci       Date:  2018-05-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.